J Turki

2.0k total citations · 1 hit paper
9 papers, 1.6k citations indexed

About

J Turki is a scholar working on Physiology, Molecular Biology and Animal Science and Zoology. According to data from OpenAlex, J Turki has authored 9 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 6 papers in Molecular Biology and 3 papers in Animal Science and Zoology. Recurrent topics in J Turki's work include Receptor Mechanisms and Signaling (6 papers), Asthma and respiratory diseases (4 papers) and Adipose Tissue and Metabolism (3 papers). J Turki is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Asthma and respiratory diseases (4 papers) and Adipose Tissue and Metabolism (3 papers). J Turki collaborates with scholars based in United States, Switzerland and Canada. J Turki's co-authors include Stephen B. Liggett, Michael A. Innis, Stuart A. Green, Ian P. Hall, P.A. Bejarano, Richard J. Martin, Juno Pak, Shulamite A. Green, John N. Lorenz and Elizabeth Donnelly and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Biochemistry.

In The Last Decade

J Turki

9 papers receiving 1.5k citations

Hit Papers

Amino-Terminal Polymorphisms of the Human .beta.2-Adrener... 1994 2026 2004 2015 1994 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Turki United States 7 951 735 374 340 270 9 1.6k
RICK J. SCHIEBINGER United States 20 225 0.2× 545 0.7× 100 0.3× 62 0.2× 700 2.6× 42 1.5k
Jamshid Latifpour United States 21 439 0.5× 443 0.6× 100 0.3× 25 0.1× 125 0.5× 75 1.4k
Akira Ohneda Japan 22 390 0.4× 376 0.5× 58 0.2× 86 0.3× 62 0.2× 112 1.9k
L Hellström Sweden 12 727 0.8× 244 0.3× 40 0.1× 117 0.3× 164 0.6× 18 1.2k
Régent Laporte United States 16 450 0.5× 655 0.9× 147 0.4× 13 0.0× 263 1.0× 29 1.4k
TW Evans United Kingdom 16 562 0.6× 205 0.3× 461 1.2× 20 0.1× 168 0.6× 46 1.2k
Stanley S. Greenberg United States 15 380 0.4× 162 0.2× 121 0.3× 13 0.0× 172 0.6× 36 914
Mary Erickson United States 9 1.0k 1.1× 455 0.6× 66 0.2× 18 0.1× 272 1.0× 13 2.0k
J. P. Coghlan Australia 20 109 0.1× 332 0.5× 157 0.4× 28 0.1× 342 1.3× 51 1.1k
Yasumichi Mori Japan 18 485 0.5× 901 1.2× 92 0.2× 17 0.1× 150 0.6× 50 1.8k

Countries citing papers authored by J Turki

Since Specialization
Citations

This map shows the geographic impact of J Turki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Turki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Turki more than expected).

Fields of papers citing papers by J Turki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Turki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Turki. The network helps show where J Turki may publish in the future.

Co-authorship network of co-authors of J Turki

This figure shows the co-authorship network connecting the top 25 collaborators of J Turki. A scholar is included among the top collaborators of J Turki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Turki. J Turki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Hogan, Alexandra M., et al.. (2025). Cost-Effectiveness of Adjuvant Alectinib Versus Chemotherapy for Patients with Resectable, ALK-positive Non-small Cell Lung Cancer in Canada. PharmacoEconomics. 43(7). 805–817. 1 indexed citations
2.
Turki, J, et al.. (1996). Myocardial signaling defects and impaired cardiac function of a human beta 2-adrenergic receptor polymorphism expressed in transgenic mice.. Proceedings of the National Academy of Sciences. 93(19). 10483–10488. 143 indexed citations
3.
Turki, J & Stephen B. Liggett. (1995). Receptor-Specific Functional Properties of β2-Adrenergic Receptor Autoantibodies in Asthma. American Journal of Respiratory Cell and Molecular Biology. 12(5). 531–539. 18 indexed citations
4.
Turki, J, et al.. (1995). Influence of β2-Adrenergic Receptor Genotypes on Signal Transduction in Human Airway Smooth Muscle Cells. American Journal of Respiratory Cell and Molecular Biology. 13(1). 25–33. 356 indexed citations
5.
Turki, J, et al.. (1995). Implications of Genetic Variability of Human β2-adrenergic Receptor Structure. Pulmonary Pharmacology. 8(1). 1–10. 78 indexed citations
6.
Turki, J, Juno Pak, Shulamite A. Green, Richard J. Martin, & Stephen B. Liggett. (1995). Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype.. Journal of Clinical Investigation. 95(4). 1635–1641. 313 indexed citations
7.
Turki, J, et al.. (1995). Human lung cell beta 2-adrenergic receptors desensitize in response to in vivo administered beta-agonist. American Journal of Physiology-Lung Cellular and Molecular Physiology. 269(5). L709–L714. 36 indexed citations
8.
Green, Stuart A., J Turki, Michael A. Innis, & Stephen B. Liggett. (1994). Amino-Terminal Polymorphisms of the Human .beta.2-Adrenergic Receptor Impart Distinct Agonist-Promoted Regulatory Properties. Biochemistry. 33(32). 9414–9419. 623 indexed citations breakdown →
9.
Green, Stuart, J Turki, Michael A. Innis, & Stephen B. Liggett. (1994). Corrections - Amino-Terminal Polymorphisms of the Human β2-Adrenergic Receptor Impart Distinct Agonist-Promoted Regulatory Properties. Biochemistry. 33(47). 14368–14368. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026